• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN MFG SOLUTIONS S.A. MAHURKAR; CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN MFG SOLUTIONS S.A. MAHURKAR; CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS Back to Search Results
Model Number 8813793009
Device Problems Material Frayed (1262); Difficult to Remove (1528)
Patient Problem Radiation Exposure, Unintended (3164)
Event Date 10/10/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the reporter, during the implantation procedure, the guidewire was introduced into the patient through the puncture needle.The needle was withdrawn and the two dilators were inserted.After dilation, the catheter was inserted through the guidewire.In the removal of the guidewire, it did not move and there was resistance.They had to remove both the catheter and guidewire from the insertion site.After it was removed from the patient, the guidewire was removed from the catheter using force which caused one wire to tear and rupture (but not completely separated).The catheter was not repaired and there was no leak.Tego was not utilized and there was no luer adapter issue.They had to perform x-ray as a precaution that all parts were recovered and no fragments were identified.The guidewire used was the one provided/included in the kit.Dry gauze was used as a cleaning agent on the device and the insertion site was treated with chlorhexidine degermante 2% for skin degeneration in jugular prior to product placement.Nothing unusual was observed on the device prior to use and there was no damage to the case and packaging.They had to use a replacement product from another brand to complete the procedure the next day.There was no medical or surgical intervention needed to prevent a permanent impairment of a function and it did not lead to or extend patient hospitalization.
 
Manufacturer Narrative
Evaluation summary: post market vigilance (pmv) led an evaluation of one device.The visual inspection of the returned product noted: only the guide wire was received.The guide wire was coiled and unraveled.The condition in which the device was received precludes functional testing.Records from each manufacturing lot are thoroughly reviewed to ensure that products are released meeting all quality release specifications at the time of manufacture.Replication of the coiled and unraveled guide wire may occur when mishandled during clinical application.The root cause of the observed damage was found to be due to the device not being used as intended which caused or contributed to the reported condition.No further actions have been deemed necessary at this time.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional info: b5, g4.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
According to the reporter, during the implantation procedure, the guidewire was introduced into the patient through the puncture needle.The needle was withdrawn and the two dilators were inserted.After dilation, the catheter was inserted through the guidewire.In the removal of the guidewire, it did not move and there was resistance.They had to remove both the catheter and guidewire from the insertion site.After it was removed from the patient, the guidewire was removed from the catheter using force which caused one wire to tear and rupture (but not completely separated).The catheter was not repaired and there was no leak.Tego was not utilized and there was no luer adapter issue.They had to perform x-ray as a precaution that all parts were recovered and no fragments were identified.The guidewire used was the one provided/included in the kit.Dry gauze was used as a cleaning agent on the device and the insertion site was treated with chlorhexidine degermante 2% for skin degeneration in jugular prior to product placement.Nothing unusual was observed on the device prior to use and there was no damage to the case and packaging.They had to use a replacement product from another brand to complete the procedure the next day.There were no patient symptoms or complications associated with this event.There was no medical or surgical intervention needed to prevent a permanent impairment of a function and it did not lead to or e xtend patient hospitalization.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MAHURKAR
Type of Device
CATHETER,INTRAVASCULAR,THERAPEUTIC,SHORT-TERM LESS THAN 30 DAYS
Manufacturer (Section D)
COVIDIEN MFG SOLUTIONS S.A.
edificio b20, calle #2
alajuela 20101
MDR Report Key9331299
MDR Text Key167159882
Report Number3009211636-2019-00244
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier10884521004801
UDI-Public10884521004801
Combination Product (y/n)N
PMA/PMN Number
K943349
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 03/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/15/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/20/2022
Device Model Number8813793009
Device Catalogue Number8813793009
Device Lot Number1729300127
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/19/2020
Date Manufacturer Received03/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-